Abbott Ventricular Tachycardia PAS

Active, not recruitingOBSERVATIONAL
Enrollment

62

Participants

Timeline

Start Date

July 24, 2023

Primary Completion Date

August 31, 2026

Study Completion Date

November 30, 2026

Conditions
Ventricular Tachycardia
Interventions
DEVICE

FlexAbility SE Ablation Catheter

Subjects receive ablation treatment.

Trial Locations (11)

28203

Carolinas Medical Center, Charlotte

29425

Medical University of South Carolina, Charleston

34102

NCH Healthcare System, Naples

37232

Vanderbilt Heart & Vascular Institute, Nashville

55417

VA Medical Center Minneapolis, Minneapolis

66211

Kansas City Cardiac Arrhythmia Research Foundation, Overland Park

73112

Integris Baptist Medical Center, Oklahoma City

75226

Baylor Scott & White Heart & Vascular Hospital, Dallas

84132

University of Utah Hospital, Salt Lake City

46240-0970

St. Vincent Hospital, Indianapolis

02114

Massachusetts General Hospital, Boston

Sponsors
All Listed Sponsors
lead

Abbott Medical Devices

INDUSTRY

NCT05839873 - Abbott Ventricular Tachycardia PAS | Biotech Hunter | Biotech Hunter